My mission when I launched the sportEX journals, was to create an ethical, fair, professionally responsible business for everyone we worked with, be it subscribers, content creators, suppliers and advertisers. It’s taken me 16 years to bring this to fruition with the launch of our new content platform (under a new brand that gives us a wider editorial remit, Co-Kinetic). This post gives an overview of how we hope that will work.
This article outlines how content is valued, the basis on which royalties are calculated, how payments are made and what builds value in a content contribution. It's a "must read" for all authors and content... Read More
This post explains why the co-operative nature of this new site is so fundamental and also what that means in practical terms in the way the site itself functions. If you're interested in business models,... Read More
The following article was adapted from an excellent paper published by the Journal of the American Academy of Family Physicians (AAFP) and gives an excellent structure detailing how to write a clinical review article
This article explains how we have transitioned our current subscribers to our new site and how to log in.
This article explains what to do if you are having password issues and also a bit about the differences between our old sportEX.net website and this new content website.
Here's a few things you might want to know about the new site like such as what can you find and where, what's the difference between sportEX and Co-Kinetic, why the rebrand, what to do next and how the content categories and subscriptions work.
This article answers some frequently asked questions about payments and payment processing for both our current system under the Co-Kinetic website as well as under our old sportEX.net site
This article sets out to explain the drivers and philosophy behind the new sportEX and Co-Kinetic website. This article is publicly available.
The Co-Kinetic journal features the best articles and content that has been published on the Co-Kinetic site that quarter. The journal is published quarterly (Jan, Apr, July, Oct) in full colour and is available worldwide (at last count we were posting to 32 different countries). It contains articles on clinical and business growth content designed to help keep you up to date and save you time (and money).
Please note that the print-only option does not include any digital access to the additional resources that may be listed in the print version of the articles. It also does not include access to the certificated elearning modules, audio versions of the articles or any other multimedia contents.
This document outlines the main responsibilities of the commissioning editors along with quick links to forms and information that you'll need during the commissioning process and that authors will need when submitting their content.
In the previous issue (sportEX dynamics 2015;43:8–11 (Jan 2015)), Brad Hiskins wrote about the situation concerning professional standards in the soft tissue industry in Australia. In a response to his article, Paul Medlicott voices his thoughts about the situation in the UK – how is it similar or different and what can we learn from Australia?
Thank you. Your account has been created and you have now been logged in. We will send you an email so that you can set your password for future use.
Unfortunately your current subscription does not include access to the new Co-Kinetic Business Growth and Marketing section. This is either because you have an old legacy Full Site subscription which requires an upgrade or you have another subscription which doesn't include access to the Business Growth element of the site.
This new part of the Co-Kinetic platform is designed to:
To access this new section, we need you to upgrade to add the Business Growth subscription to your account. (more details here).
Don't worry, it's RISK FREE. If you don't wish your subscription to continue after this time, simply
cancel your Business Growth subscription before the trial expires and your original content
subscription will continue as before.